Pictet Asset Management (UK)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$631K Sell
3,900
-600
-13% -$97.1K ﹤0.01% 1166
2021
Q1
$548K Buy
4,500
+100
+2% +$12.2K ﹤0.01% 1161
2020
Q4
$674K Buy
4,400
+200
+5% +$30.6K ﹤0.01% 1075
2020
Q3
$351K Buy
+4,200
New +$351K ﹤0.01% 1171